Martina Di Bartolomeo

Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia

Tibor Štark, Jana Kučerová, Fabio Arturo Iannotti et al. · Neuropharmacology · 2018 · 88 citations

Psychotropic Medication, Psychopharmacology, Neuropsychiatry +16

A preliminary study of endocannabinoid system regulation in psychosis: Distinct alterations of CNR1 promoter DNA methylation in patients with schizophrenia

Claudio D’Addario, Vincenzo Micale, Martina Di Bartolomeo et al. · Schizophrenia Research · 2017 · 76 citations

Cannabis Use, Psychiatry, Psychotic Disorder +12

Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: Analyses in patients and in perinatal Δ9-tetrahydrocannabinol-exposed rats

Martina Di Bartolomeo, Tibor Štark, Oriana Maria Maurel et al. · Pharmacological Research · 2020 · 69 citations · Full text

Cannabis Use, Transcriptional Regulation, Psychiatry +14

Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment

Tibor Štark, Martina Di Bartolomeo, Roberta Di Marco et al. · Biochemical Pharmacology · 2020 · 62 citations

Psychoactive Drug, Psychiatry, Medicine +11

Transcriptional and epigenetic phenomena in peripheral blood cells of monozygotic twins discordant for alzheimer’s disease, a case report

Claudio D’Addario, Sussy Bastías‐Candia, Beatrice Arosio et al. · Journal of the Neurological Sciences · 2016 · 33 citations

Chromatin, Alzheimer's Disease, Monozygotic Twins +9